Key facts
- This page summarizes Charles J. Hall's Form 4 filing for HCA Healthcare, Inc. (HCA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Nov 2022, 16:37.
Charles J. Hall - 11 Nov 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)
- Reporting relationship
- Group President
- Issuer ticker
- HCA
- Reported as of
- 11 Nov 2022
- Net transaction value
- -$372,435
- SEC form
- 4
- Accepted by SEC
- 15 Nov 2022, 16:37:48 UTC
- Prior SEC filing
- 01 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Natalie Harrison Cline, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Charles J. Hall filed Form 4 for HCA Healthcare, Inc. (HCA) on 15 Nov 2022.
Change
- Previous filing in this sequence was filed on 01 Nov 2022.
- Current net transaction value: -$372,435.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HCA
transaction
Common Stock
Options Exercise
- Transaction value
- $1,742,880
- Shares
- +12,000
- Change %
- +6%
- Price
- $145.24
- Shares after
- 211,883
- Date
- 11 Nov 2022
- Ownership
- Direct
HCA
transaction
Common Stock
Tax liability
- Transaction value
- $2,115,315
- Shares
- -9,440
- Change %
- -4.5%
- Price
- $224.08
- Shares after
- 202,443
- Date
- 11 Nov 2022
- Ownership
- Direct
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,525
- Date
- 11 Nov 2022
- Ownership
- By 2021 Family GRAT
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HCA
transaction
Derivative
Stock Appreciation Right
Options Exercise
- Transaction value
- $0
- Shares
- -12,000
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 23,880
- Date
- 11 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,000
- Exercise price
- $145.24
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.